Unrestrictive identification of post-translational modifications in the urine proteome without enrichment

被引:13
作者
Liu, Liu [3 ]
Liu, Xuejiao [2 ]
Sun, Wei [1 ]
Li, Mingxi [2 ]
Gao, Youhe [3 ]
机构
[1] Chinese Acad Med Sci, Peking Union Med Coll, Inst Basic Med Sci, Dept Core Instrument Facil, Beijing 100005, Peoples R China
[2] Peking Union Med Coll Hosp, Dept Nephrol, Beijing, Peoples R China
[3] Chinese Acad Med Sci, Sch Basic Med, Dept Physiol & Pathophysiol, Inst Basic Med Sci,Natl Key Lab Med Mol Biol, Beijing 100005, Peoples R China
来源
PROTEOME SCIENCE | 2013年 / 11卷
基金
国家高技术研究发展计划(863计划);
关键词
Urine proteomics; MODa; PEAKS; 6; PTMs without enrichment; In vivo PTMs;
D O I
10.1186/1477-5956-11-1
中图分类号
Q5 [生物化学];
学科分类号
071010 ; 081704 ;
摘要
Background: Research on the human urine proteome may lay the foundation for the discovery of relevant disease biomarkers. Post-translational modifications (PTMs) have important effects on the functions of protein biomarkers. Identifying PTMs without enrichment adds no extra steps to conventional identification procedures for urine proteomics. The only difference is that this method requires software that can conduct unrestrictive identifications of PTMs. In this study, routine urine proteomics techniques were used to identify urine proteins. Unspecified PTMs were searched by MODa and PEAKS 6 automated software, followed by a manual search to screen out in vivo PTMs by removing all in vitro PTMs and amino acid substitutions. Results: There were 75 peptides with 6 in vivo PTMs that were found by both MODa and PEAKS 6. Of these, 34 peptides in 18 proteins have novel in vivo PTMs compared with the annotation information of these proteins on the Universal Protein Resource website. These new in vivo PTMs had undergone methylation, dehydration, oxidation, hydroxylation, phosphorylation, or dihydroxylation. Conclusions: In this study, we identified PTMs of urine proteins without the need for enrichment. Our investigation may provide a useful reference for biomarker discovery in the future.
引用
收藏
页数:9
相关论文
共 15 条
[1]   Glycated and oxidized protein degradation products are indicators of fasting and postprandial hyperglycemia in diabetes [J].
Ahmed, N ;
Babaei-Jadidi, R ;
Howell, SK ;
Thornalley, PJ ;
Beisswenger, PJ .
DIABETES CARE, 2005, 28 (10) :2465-2471
[2]   Post-translational modification and proteolytic processing of urinary osteopontin [J].
Christensen, Brian ;
Petersen, Torbert E. ;
Sorensen, Esben S. .
BIOCHEMICAL JOURNAL, 2008, 411 :53-61
[3]   Human Urinary Glycoproteomics; Attachment Site Specific Analysis of N- and O-Linked Glycosylations by CID and ECD [J].
Halim, Adnan ;
Nilsson, Jonas ;
Ruetschi, Ulla ;
Hesse, Camilla ;
Larson, Goran .
MOLECULAR & CELLULAR PROTEOMICS, 2012, 11 (04)
[4]   PeaksPTM: Mass Spectrometry-Based Identification of Peptides with Unspecified Modifications [J].
Han, Xi ;
He, Lin ;
Xin, Lei ;
Shan, Baozhen ;
Ma, Bin .
JOURNAL OF PROTEOME RESEARCH, 2011, 10 (07) :2930-2936
[5]   Comparative urine protein phenotyping using mass spectrometric immunoassay [J].
Kiernan, UA ;
Tubbs, KA ;
Nedelkov, D ;
Niederkofler, EE ;
McConnell, E ;
Nelson, RW .
JOURNAL OF PROTEOME RESEARCH, 2003, 2 (02) :191-197
[6]   A comprehensive and non-prefractionation on the protein level approach for the human urinary proteome: touching phosphorylation in urine [J].
Li, Qing-Run ;
Fan, Ke-Xin ;
Li, Rong-Xia ;
Dai, Jie ;
Wu, Chao-Chao ;
Zhao, Shi-Lin ;
Wu, Jia-Rui ;
Shieh, Chia-Hui ;
Zeng, Rong .
RAPID COMMUNICATIONS IN MASS SPECTROMETRY, 2010, 24 (06) :823-832
[7]   Identification of rat urinary glycoproteome captured by three lectins using gel and LC-based proteomics [J].
Moon, Pyong-Gon ;
Hwang, Hyun-Ho ;
Boo, Yong Chool ;
Kwon, Joseph ;
Cho, Je-Yoel ;
Baek, Moon-Chang .
ELECTROPHORESIS, 2008, 29 (21) :4324-4331
[8]   Fast Multi-blind Modification Search through Tandem Mass Spectrometry [J].
Na, Seungjin ;
Bandeira, Nuno ;
Paek, Eunok .
MOLECULAR & CELLULAR PROTEOMICS, 2012, 11 (04)
[9]   The urinary proteome in diabetes and diabetes-associated complications: New ways to assess disease progression and evaluate therapy [J].
Rossing, Kasper ;
Mischak, Harald ;
Rossing, Peter ;
Schanstra, Joost P. ;
Wiseman, Alex ;
Maahs, David M. .
PROTEOMICS CLINICAL APPLICATIONS, 2008, 2 (7-8) :997-1007
[10]  
Thongboonkerd V, 2002, KIDNEY INT, V62, P1461, DOI 10.1111/j.1523-1755.2002.kid565.x